Institutional investors purchased a net $178.8 thousand shares of MBOT during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 5.17% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 145.1 Thousand shares of Microbot Medical Inc
CITADEL ADVISORS LLC Bought 69.9 Thousand shares of Microbot Medical Inc
ZEKE CAPITAL ADVISORS LLC Bought 40.0 Thousand shares of Microbot Medical Inc